| Systemic treatment of renal cell cancer: A comprehensive review A Sánchez-Gastaldo, E Kempf, AG Del Alba, I Duran Cancer treatment reviews 60, 77-89, 2017 | 152 | 2017 |
| KRAS oncogene in lung cancer: focus on molecularly driven clinical trials E Kempf, B Rousseau, B Besse, L Paz-Ares European respiratory review 25 (139), 71-76, 2016 | 112 | 2016 |
| Quelle utilité des directives anticipées pour les médecins? V Fournier, D Berthiau, E Kempf, J d’Haussy La presse médicale 42 (6), e159-e169, 2013 | 62 | 2013 |
| Two cases of immune thrombocytopenia associated with pembrolizumab A Le Roy, E Kempf, F Ackermann, E Routier, C Robert, A Turpin, ... European Journal of Cancer 54, 172-174, 2016 | 54 | 2016 |
| New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: a persistent and concerning decrease long after the end of the national lockdown E Kempf, G Lamé, R Layese, S Priou, G Chatellier, H Chaieb, ... European Journal of Cancer 150, 260-267, 2021 | 43 | 2021 |
| Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review E Kempf, JA de Beyer, J Cook, J Holmes, S Mohammed, TL Nguyên, ... British journal of cancer 119 (10), 1288-1296, 2018 | 28 | 2018 |
| First-line antiangiogenics for metastatic renal cell carcinoma: a systematic review and network meta-analysis B Rousseau, E Kempf, G Desamericq, E Boissier, M Chaubet-Houdu, ... Critical Reviews in Oncology/Hematology 107, 44-53, 2016 | 26 | 2016 |
| Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide … E Kempf, C Tournigand, P Rochigneux, R Aubry, L Morin European Journal of Cancer 79, 31-40, 2017 | 25 | 2017 |
| ‘Mind the gap’between the development of therapeutic innovations and the clinical practice in oncology: a proposal of the European Organisation for Research and Treatment of … E Kempf, J Bogaerts, D Lacombe, L Liu European Journal of Cancer 86, 143-149, 2017 | 24 | 2017 |
| Complete response in anaplastic lymphoma kinase–rearranged oncocytic thyroid cancer: A case report and review of literature V De Salins, G Loganadane, C Joly, M Abulizi, M Nourieh, H Boussion, ... World Journal of Clinical Oncology 11 (7), 495, 2020 | 21 | 2020 |
| Impact of two waves of Sars‐Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: a French … E Kempf, S Priou, G Lamé, C Daniel, A Bellamine, D Sommacale, ... International Journal of Cancer 150 (10), 1609-1618, 2022 | 19 | 2022 |
| Challenges in diagnosis and treatment of lung cancer in people with intellectual disabilities: current state of knowledge D Satgé, E Kempf, JB Dubois, M Nishi, J Trédaniel Lung cancer international 2016 (1), 6787648, 2016 | 18 | 2016 |
| Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia E Kempf, P Hirsch, M Labopin, F Viguié, F Isnard, R Tang, C Marzac, ... Leukemia research 38 (12), 1425-1429, 2014 | 18 | 2014 |
| Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma J Calderaro, L Di Tommaso, P Maillé, A Beaufrère, CT Nguyen, L Heij, ... Journal of hepatology 77 (6), 1586-1597, 2022 | 16 | 2022 |
| Clinical characteristics, care trajectories and mortality rate of SARS-CoV-2 infected cancer patients: a multicenter cohort study MA Benderra, A Aparicio, J Leblanc, D Wassermann, E Kempf, G Galula, ... Cancers 13 (19), 4749, 2021 | 15 | 2021 |
| 10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient E Kempf, D Planchard, T Le Chevalier, JC Soria European Respiratory Journal 46 (1), 280-282, 2015 | 15 | 2015 |
| Are advance directives useful for doctors and what for? V Fournier, D Berthiau, E Kempf, J d'Haussy Presse Medicale (Paris, France: 1983) 42 (6 Pt 1), e159-69, 2013 | 15 | 2013 |
| Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma J Calderaro, N Ghaffari Laleh, Q Zeng, P Maille, L Favre, A Pujals, C Klein, ... Nature communications 14 (1), 8290, 2023 | 11 | 2023 |
| A case-control study brings to light the causes of screen failures in phase 1 cancer clinical trials E Kempf, N Lemoine, G Tergemina-Clain, A Turpin, S Postel-Vinay, ... PLoS One 11 (5), e0154895, 2016 | 11 | 2016 |
| L’informatisation de l’aide à la décision: la décision médicale est-elle indemne? L’exemple d’un outil prédictif en cancérologie A Kempf, E Kempf Revue française d’éthique appliquée, 59-70, 2016 | 11 | 2016 |
